Larson Financial Group
NAGE icon

Larson Financial Group’s Niagen Bioscience NAGE Stock Holding History

Larson Financial Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.46K Sell
500
-17
-3% -$54 ﹤0.01% 3313
2026
Q2 		$1.65K Sell
517
-86
-14% -$349 ﹤0.01% 3174
2026
Q1 		$2.66K Buy
603
+507
+528% +$2.74K ﹤0.01% 2872
2025
Q4 		$611 Buy
96
+61
+174% +$424 ﹤0.01% 3076
2025
Q3 		$327 Sell
35
-2
-5% -$20 ﹤0.01% 3183
2025
Q2 		$533 Buy
+37
New +$365 ﹤0.01% 2840

Other funds holding NAGE

SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Larson Financial Group's NAGE Position: Q3 2026 in Review

Larson Financial Group reduced its Niagen Bioscience (NAGE) stake by 3.3% in Q3 2026, selling an estimated $54 and leaving 500 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3313.

Larson Financial Group first reported a position in NAGE in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.66K in Q1 2026. 52 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.

  • Larson Financial Group held 500 shares of Niagen Bioscience worth $1.46K as of Q3 2026.
  • Larson Financial Group sold 17 Niagen Bioscience shares in Q3 2026, an estimated $54.
  • Niagen Bioscience made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3313 holding.
  • Larson Financial Group first reported a position in Niagen Bioscience in Q2 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Niagen Bioscience position peaked at $2.66K in Q1 2026.
  • 52 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.